![Pete Shagory](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pete Shagory
Corporate Officer/Principal presso
CONMED CORPORATION
Patrimonio netto: 180 431 $ in data 31/07/2026
Profilo
Mr. Pete K.
Shagory is an Executive VP-Strategy & Corporate Development at CONMED Corp.
Mr. Shagory was previously employed as a Partner by Robert W.
Baird & Co., Inc. /Venture Partners/, a Manager by Banc One Capital Markets, Inc., a Manager by J.P.
Morgan & Co., Inc. (Old), and a Portfolio Manager by Vector Asset Management, Inc. He also served on the board at Accuri Cytometers, Inc., Arbor Surgical Technologies, Inc., Wisconsin Biotechnology & Medical Device Association, Caden Biosciences, Inc., CoAxia, Inc., Core Essence Orthopaedics, Inc., Molecular Imaging, Inc. and NimbleGen Systems, Inc. He received his undergraduate degree from Miami University and an MBA from Tuck School of Business at Dartmouth.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CONMED CORPORATION 0,01% | 24/03/2026 | 3.897 ( 0,01% ) | 180 431 $ | 31/07/2026 |
Posizioni attive di Pete Shagory
| Società | Posizione | Inizio |
|---|---|---|
| CONMED CORPORATION | Corporate Officer/Principal | 11/05/2015 |
Precedenti posizioni note di Pete Shagory
| Società | Posizione | Fine |
|---|---|---|
Robert W. Baird & Co., Inc. /Venture Partners/
 Robert W. Baird & Co., Inc. /Venture Partners/ Investment ManagersFinance Baird Capital invests in middle market companies located in the United States with annual revenues of USD 5 - 25 million. The firm focuses on B2B technology & services sectors. It participates in early to growth stage transactions with an investment size of USD 15 - 25 million. The firm acquires majority and minority stakes. It also takes a seat on the board of directors. | Investitore di Private Equity | 01/06/2013 |
Caden Biosciences, Inc.
 Caden Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops assays for G-protein coupled receptors | Direttore/Membro del Consiglio | 10/09/2009 |
Bioforward, Inc.
 Bioforward, Inc. Investment ManagersFinance Alternative investment manager | Corporate Officer/Principal | 31/12/2008 |
NimbleGen Systems, Inc.
 NimbleGen Systems, Inc. BiotechnologyHealth Technology Develops micro-arrays used in bio-technology | Direttore/Membro del Consiglio | 30/12/2008 |
Vector Asset Management, Inc.
 Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management invests in later-stage private and public companies in the life sciences and healthcare industries. Specific areas of interest include: biotechnology, pharmaceuticals, medical devices, diagnostics, plant and animal sciences, healthcare services, healthcare information technology and consumer applications of emerging healthcare technologies. They focus on companies that are raising capital in the private markets prior to the point at which they can access the public markets or execute an alternative exit strategy. Vector looks for companies ready to move from development stage to commercially viable operating entities in a relatively short time. The firm also participates in equity transactions involving securities of small- to mid-cap public companies in the life sciences and healthcare area. Most of Vector's investments are negotiated directly with company management. Vector is an active investor and generally leads or co-leads their investments. They usually serve on the Board of Directors of their portfolio companies. Investments range from $5 million to $15 million with an investment horizon of one to three years. | Investitore di Private Equity | 30/12/2003 |
Formazione di Pete Shagory
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
54
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
CONMED Corp.
 CONMED Corp. Medical SpecialtiesHealth Technology Operates as a medical technology company, which provides surgical devices and equipment for minimally invasive procedures and monitoring | Health Technology |
CoAxia, Inc.
 CoAxia, Inc. Medical/Nursing ServicesHealth Services Develops & markets technologies to reduce neurologic damage | Health Services |
Accuri Cytometers, Inc.
 Accuri Cytometers, Inc. Medical SpecialtiesHealth Technology Develops and manufactures personal flow cytometers | Health Technology |
Arbor Surgical Technologies, Inc.
 Arbor Surgical Technologies, Inc. Medical SpecialtiesHealth Technology Develops cardiovascular medical devices | Health Technology |
Caden Biosciences, Inc.
Caden Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops assays for G-protein coupled receptors | Health Technology |
Banc One Capital Markets, Inc.
 Banc One Capital Markets, Inc. Investment Banks/BrokersFinance Provides security brokerage services | Finance |
J.P. Morgan & Co., Inc. (Old)
 J.P. Morgan & Co., Inc. (Old) Regional BanksFinance Provides commercial banking and investment advisory services | Finance |
NimbleGen Systems, Inc.
NimbleGen Systems, Inc. BiotechnologyHealth Technology Develops micro-arrays used in bio-technology | Health Technology |
Miami University
 Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert W. Baird & Co., Inc. /Venture Partners/
Robert W. Baird & Co., Inc. /Venture Partners/ Investment ManagersFinance Baird Capital invests in middle market companies located in the United States with annual revenues of USD 5 - 25 million. The firm focuses on B2B technology & services sectors. It participates in early to growth stage transactions with an investment size of USD 15 - 25 million. The firm acquires majority and minority stakes. It also takes a seat on the board of directors. | Finance |
Bioforward, Inc.
Bioforward, Inc. Investment ManagersFinance Alternative investment manager | Finance |
Vector Asset Management, Inc.
Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management invests in later-stage private and public companies in the life sciences and healthcare industries. Specific areas of interest include: biotechnology, pharmaceuticals, medical devices, diagnostics, plant and animal sciences, healthcare services, healthcare information technology and consumer applications of emerging healthcare technologies. They focus on companies that are raising capital in the private markets prior to the point at which they can access the public markets or execute an alternative exit strategy. Vector looks for companies ready to move from development stage to commercially viable operating entities in a relatively short time. The firm also participates in equity transactions involving securities of small- to mid-cap public companies in the life sciences and healthcare area. Most of Vector's investments are negotiated directly with company management. Vector is an active investor and generally leads or co-leads their investments. They usually serve on the Board of Directors of their portfolio companies. Investments range from $5 million to $15 million with an investment horizon of one to three years. | Finance |
Core Essence Orthopaedics, Inc.
 Core Essence Orthopaedics, Inc. Medical SpecialtiesHealth Technology Develops and manufactures minimally invasive soft tissue and arthroscopic musculoskeletal surgical solutions | Health Technology |
Molecular Imaging, Inc.
 Molecular Imaging, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research services supported by extensive in vivo imaging capabilities | Commercial Services |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
